The sequencing of normal DNA and tumour DNA is now common practice. However, there is little use for large-scale genome or exome sequencing of patient and tumour DNA in the clinical environment unless ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the introduction of a three-year plan to add GS1 Data Matrix barcodes to its pharmaceutical portfolio of vials, syringes, IV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback